BONECHIP

Welcome to the Brand page for “BONECHIP”, which is offered here for Antibodies, proteins and peptides for medical use in detecting, analyzing and measuring proteins; pharmaceutical and biochemical substances and preparations, pharmaceutical preparations for the treatment of osteoporosis, disease relating to altered bone mineral density, altered bone strength, bone damage, bone disorders and bone diseases; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use; diagnostic and prognostic products for medical purposes, medical diagnostic reagents;bone chip;chemical preparations, enzymes, labelled probes and oligonucleotides for use in analyzing proteins, dna, messenger rna, rna; products for the separation, detection, measurement and analysis of proteins, and for the isolation and production of recombinants, chemical buffer solutions and nucleic acid resolving materials; all for industrial, agricultural, environmental and food purposes;medical and surgical services; osteoporosis diagnostic and prognostic services; medical counseling in the nature of information and advice in the fields of medicine and surgery;apparatus and instruments for diagnostic and therapeutic research, mri, ultrasound, dexa scanner x ray, diagnostic apparatus and diagnostic chips; display apparatus, multi-well plates and arrays for diagnosis and analysis;biotechnology testing services; quality control services for others in pharmaceuticals; technical research and development in the field of biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “BONECHIP” is believed to be currently owned by “Oxagen Limited”.